Numerous studies have highlighted the aberrant expression of CACYBP in several malignant cancers like glioma [12], breast cancer (BC) [13], gastric cancer (GC) [14], colon cancer [15] and pancreatic cancer [16]. This evidence concerns the gene CACYBP and breast cancer.